InvestorsHub Logo

beartrap12

05/16/24 6:46 AM

#691949 RE: skitahoe #691935

First, Gary, Flaskworks is NWBO. We own the the Eden system. I think you mean that you believe NWBO will remain "quite small' in terms of personnel, not income. I think their income from DCVax will be huge and I think they'll bring on whatever personnel they need to do the job. I agree that we'll be paying CRL a decent amount for manufacturing and cryopresrvation, and that they stand to benefit finanially very well and couldl eventually probably do more of the work of manufacturing in the world than NWBO's one Sawston's plant. However, as the owner, we will do even better. It's a lot like selling photography. Most photographers send their pictures out to be printed by a lab, and they make less per picture. I do my own printing, so I save that cost, but it costs me more in time and labor. There were years when the manufacturing of my pictures cut into time I could have been out photographing. It's a trade-off.
I think NWBO is about to make themselves and a lot of other companies a lot of money. The word franchise means a lot of licensing out to other companies. Think of McDonalds. Do you really think the main company suffers from having thousands of individuals who own a franchise and run it themselves?
Bullish
Bullish

attilathehunt

05/16/24 9:56 AM

#691980 RE: skitahoe #691935

does CRL pay NWBO for the rights to produce the vaccine and use the EDEN units, or is it the other way around with NWBO paying them to do it.



Thinking of the franchise model, I would think there is a monthly rental on the unit plus $x for each dose. Let the hospitals and pharmacies deal with the insurance reimbursement and patient collections...NWBO can then sit back and review the daily usage reports! Won't need many he's to do that.